Nordic Urinary Catheters Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,850	158 Pages	Fortune Business Insights Pvt. Ltd.	October, 2024	FOB19260751

Best Price Guarantee
Price	from $4,850
Length	158 Pages
Publisher	Fortune Business Insights Pvt. Ltd.
Published Date	October, 2024
SKU	FOB19260751

Nordic Urinary Catheters Market

Growth Factors of Nordic Urinary Catheters Market

The Nordic urinary catheters market size was valued at USD 68.6 million in 2022, and the market is now projected to grow from USD 72.8 million in 2023 to USD 111.1 million by 2030, exhibiting a CAGR of 6.2% during the forecast period of 2023-2030.

The Nordic urinary catheters market growth has been mildly impacted by the COVID-19 infection with delayed surgical procedures and altered hospitalizations. For instance, firms such as Coloplast A/S experienced decreases in sales. The market recovered in 2022 as many hospitals were visited more often and innovative products were implemented in 2023-2030.

The factors that have led to the increase of the Nordic urinary catheters market share are the high incidence of urinary incontinence caused by other conditions such as benign prostatic hyperplasia, diabetes and pregnancy. However, the greatest threat is afforded by the tendency towards an increase in population density, particularly the gerontology demography which implies higher incidences of incontinence. Such forecasts are expected to propel the market even further in the future.

Another prevailing issue in the Nordic market, which has attracted increased interest and customer preference from users and healthcare professionals, is the replacement of conventional urinary catheters with their technologically enhanced type. There is rising capital outlay on technology enhancements to serve this need. In addition, there is a focus towards employing green materials for the production of plastic medical devices. Advanced products’ adoption rate will probably rise significantly in the region because of the industry's higher number of innovations by major companies.

Comprehensive Analysis of Nordic Urinary Catheters Market

The Nordic urinary catheters market and healthcare industry is rising exponentially due to its market segmentation. This market expansion effectively provides detailed regional assessments considering the dominant supply and demand forces that impact the healthcare industry. These segmentations are methodically segregated by product, by application, by gender and by end- user. The products include, Indwelling Catheters, Intermittent Catheters and External Catheters. The applications include, Urinary Incontinence, Spinal Cord Injury, Gynecology, Benign Prostatic Hyperplasia, Surgery and Others. The genders include, Male and Female. The end-users include, Hospitals, Age Care Centers and Others.

The Swedish market value reached USD 24.5 million in 2022, driven by increased patient admissions, longer hospital stays and a rise in chronic diseases and surgical procedures. Norway held a significant share of the Nordic market due to enhanced healthcare facilities and greater adoption of urinary catheters. Additionally, Denmark, Finland and other Nordic countries are experiencing growth, supported by improved healthcare infrastructure, reimbursement options and rising product adoption to meet the needs of elderly patients.

The key industry players in the market play a crucial role in the healthcare industry assuring industrial prospectus growth and setting market standards. These players include, BACTIGUARD AB (Sweden), Coloplast A/S (Denmark), Convatec Group PLC (U.K.), Hollister Incorporated (U.S.), Boston Scientific Corporation (U.S.), BD (Becton, Dickinson and Company) (U.S.), B. Braun SE (Germany) and Wellspect HealthCare (Dentsply Sirona) (Denmark). These market players provide a level-playing competitive landscape.

In June 2023, Convatec Group PLC introduced GentleCath Air for women to reduce the likelihood of catheter contamination. This product is designed to provide patients with maximum convenience and comfort.

Segmentation Table

Global Nordic Urinary Catheters Market Scope

Study Period 2019-2030

Base Year 2022

Forecast Period 2023-2030

Growth Rate CAGR of 6.2% from 2023-2030

Historical Period 2019-2021

Unit Value (USD Billion)

Segmentation By Product, Application, Gender, End-User, and Country/ Sub-Region

By Product Indwelling Catheters

Intermittent Catheters

External Catheters

By Application Urinary Incontinence

Spinal Cord Injury

Gynecology

Benign Prostatic Hyperplasia

Surgery

Others

By Gender Male

Female

By End- User Hospitals

Age Care Centers

Others

By Region Nordic (By Product, By Application, By Gender, By End-User, and By Country/Sub-Region)

Sweden (By Product, By Application, By Gender, By End-User)
Norway (By Product, By Application, By Gender, By End-User)
Denmark (By Product, By Application, By Gender, By End-User)
Finland (By Product, By Application, By Gender, By End-User)
Rest of Nordic (By Product, By Application, By Gender, By End-User)

Please Note:

1. Introduction: 1.1. Research Scope; 1.2. Market Segmentation; 1.3. Research Methodology; 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics: 3.1. Market Drivers; 3.2. Market Restraints; 3.3. Market Opportunities; 3.4. Market Trends
4. Key Insights: 4.1. Distribution of the Intermittent Catheters Market Size (USD million), 2022; 4.2. Healthcare Overview (Number of Hospitals, Hospital Beds, Aged Care Centers, Healthcare Spending, etc.), By Key Nordic Countries; 4.3. Disease Prevalence of Key Diseases such as Urinary Incontinence, BPH, etc., By Key Nordic Countries; 4.4. Key Industry Developments, By Key Players; 4.5. Pricing Analysis, By Major Companies/Brands; 4.6. Technological Developments in Urinary Catheters; 4.7. Impact of COVID-19 on the Market
5. Nordic Urinary Catheters Market Analysis, Insights and Forecast, 2019-2030: 5.1. Market Analysis, Insights and Forecast – By Product; 5.1.1. Indwelling Catheters; 5.1.2. Intermittent Catheters; 5.1.3. External Catheters; 5.2. Market Analysis, Insights and Forecast – By Application; 5.2.1. Urinary Incontinence; 5.2.2. Spinal Cord Injury; 5.2.3. Gynecology; 5.2.4. Benign Prostatic Hyperplasia; 5.2.5. Surgery; 5.2.6. Others; 5.3. Market Analysis, Insights and Forecast – By Gender; 5.3.1. Male; 5.3.2. Female; 5.4. Market Analysis, Insights and Forecast – By End-User; 5.4.1. Hospitals; 5.4.2. Age Care Centers; 5.4.3. Others; 5.5. Market Analysis, Insights and Forecast – By Country/Sub-Region; 5.5.1. Sweden; 5.5.2. Norway; 5.5.3. Denmark; 5.5.4. Finland; 5.5.5. Rest of Nordic
6. Sweden Urinary Catheters Market Analysis, Insights and Forecast, 2019-2030: 6.1. Market Analysis, Insights and Forecast – By Product; 6.1.1. Indwelling Catheters; 6.1.2. Intermittent Catheters; 6.1.3. External Catheters; 6.2. Market Analysis, Insights and Forecast – By Application; 6.2.1. Urinary Incontinence; 6.2.2. Spinal Cord Injury; 6.2.3. Gynecology; 6.2.4. Benign Prostatic Hyperplasia; 6.2.5. Surgery; 6.2.6. Others; 6.3. Market Analysis, Insights and Forecast – By Gender; 6.3.1. Male; 6.3.2. Female; 6.4. Market Analysis, Insights and Forecast – By End-User; 6.4.1. Hospitals; 6.4.2. Age Care Centers; 6.4.3. Others
7. Norway Urinary Catheters Market Analysis, Insights and Forecast, 2019-2030: 7.1. Market Analysis, Insights and Forecast – By Product; 7.1.1. Indwelling Catheters; 7.1.2. Intermittent Catheters; 7.1.3. External Catheters; 7.2. Market Analysis, Insights and Forecast – By Application; 7.2.1. Urinary Incontinence; 7.2.2. Spinal Cord Injury; 7.2.3. Gynecology; 7.2.4. Benign Prostatic Hyperplasia; 7.2.5. Surgery; 7.2.6. Others; 7.3. Market Analysis, Insights and Forecast – By Gender; 7.3.1. Male; 7.3.2. Female; 7.4. Market Analysis, Insights and Forecast – By End-User; 7.4.1. Hospitals; 7.4.2. Age Care Centers; 7.4.3. Others
8. Denmark Urinary Catheters Market Analysis, Insights and Forecast, 2019-2030: 8.1. Market Analysis, Insights and Forecast – By Product; 8.1.1. Indwelling Catheters; 8.1.2. Intermittent Catheters; 8.1.3. External Catheters; 8.2. Market Analysis, Insights and Forecast – By Application; 8.2.1. Urinary Incontinence; 8.2.2. Spinal Cord Injury; 8.2.3. Gynecology; 8.2.4. Benign Prostatic Hyperplasia; 8.2.5. Surgery; 8.2.6. Others; 8.3. Market Analysis, Insights and Forecast – By Gender; 8.3.1. Male; 8.3.2. Female; 8.4. Market Analysis, Insights and Forecast – By End-User; 8.4.1. Hospitals; 8.4.2. Age Care Centers; 8.4.3. Others
9. Finland Urinary Catheters Market Analysis, Insights and Forecast, 2019-2030: 9.1. Market Analysis, Insights and Forecast – By Product; 9.1.1. Indwelling Catheters; 9.1.2. Intermittent Catheters; 9.1.3. External Catheters; 9.2. Market Analysis, Insights and Forecast – By Application; 9.2.1. Urinary Incontinence; 9.2.2. Spinal Cord Injury; 9.2.3. Gynecology; 9.2.4. Benign Prostatic Hyperplasia; 9.2.5. Surgery; 9.2.6. Others; 9.3. Market Analysis, Insights and Forecast – By Gender; 9.3.1. Male; 9.3.2. Female; 9.4. Market Analysis, Insights and Forecast – By End-User; 9.4.1. Hospitals; 9.4.2. Age Care Centers; 9.4.3. Others
10. Rest of Nordic Urinary Catheters Market Analysis, Insights and Forecast, 2019-2030: 10.1. Market Analysis, Insights and Forecast – By Product; 10.1.1. Indwelling Catheters; 10.1.2. Intermittent Catheters; 10.1.3. External Catheters; 10.2. Market Analysis, Insights and Forecast – By Application; 10.2.1. Urinary Incontinence; 10.2.2. Spinal Cord Injury; 10.2.3. Gynecology; 10.2.4. Benign Prostatic Hyperplasia; 10.2.5. Surgery; 10.2.6. Others; 10.3. Market Analysis, Insights and Forecast – By Gender; 10.3.1. Male; 10.3.2. Female; 10.4. Market Analysis, Insights and Forecast – By End-User; 10.4.1. Hospitals; 10.4.2. Age Care Centers; 10.4.3. Others
11. Competitive Analysis: 11.1. Nordic Market Share Analysis (2022); 11.2. Company Profiles; 11.2.1. BACTIGUARD AB; 11.2.1.1. Overview; 11.2.1.2. Products; 11.2.1.3. SWOT Analysis; 11.2.1.4. Recent Developments; 11.2.1.5. Strategies; 11.2.1.6. financials (Based on Availability); 11.2.2. Coloplast A/S; 11.2.2.1. Overview; 11.2.2.2. Products; 11.2.2.3. SWOT Analysis; 11.2.2.4. Recent Developments; 11.2.2.5. Strategies; 11.2.2.6. financials (Based on Availability); 11.2.3. Convatec Group PLC; 11.2.3.1. Overview; 11.2.3.2. Products; 11.2.3.3. SWOT Analysis; 11.2.3.4. Recent Developments; 11.2.3.5. Strategies; 11.2.3.6. financials (Based on Availability); 11.2.4. Hollister Incorporated; 11.2.4.1. Overview; 11.2.4.2. Products; 11.2.4.3. SWOT Analysis; 11.2.4.4. Recent Developments; 11.2.4.5. Strategies; 11.2.4.6. financials (Based on Availability); 11.2.5. Boston Scientific Corporation; 11.2.5.1. Overview; 11.2.5.2. Products; 11.2.5.3. SWOT Analysis; 11.2.5.4. Recent Developments; 11.2.5.5. Strategies; 11.2.5.6. financials (Based on Availability); 11.2.6. BD (Becton, Dickinson and Company); 11.2.6.1. Overview; 11.2.6.2. Products; 11.2.6.3. SWOT Analysis; 11.2.6.4. Recent Developments; 11.2.6.5. Strategies; 11.2.6.6. financials (Based on Availability); 11.2.7. B. Braun SE; 11.2.7.1. Overview; 11.2.7.2. Products; 11.2.7.3. SWOT Analysis; 11.2.7.4. Recent Developments; 11.2.7.5. Strategies; 11.2.7.6. financials (Based on Availability)